Expanded Access to Everolimus, for an individual patient with Uterine Sarcoma

Cancer Type

Multiple Sites

ClinicalTrials.gov Identifier

NCT03493165

Principal Investigator

John Sarantopoulos MD

For more information about this study

View Details